Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9632393.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Long-term potentiation (LTP) at the Schaffer collateral-CA1 synapse involves interacting signaling components, including calcium (Ca2+)/calmodulin-dependent protein kinase II (CaMKII) and cyclic adenosine monophosphate (cAMP) pathways. Postsynaptic injection of thiophosphorylated inhibitor-1 protein, a specific inhibitor of protein phosphatase-1 (PP1), substituted for cAMP pathway activation in LTP. Stimulation that induced LTP triggered cAMP-dependent phosphorylation of endogenous inhibitor-1 and a decrease in PP1 activity. This stimulation also increased phosphorylation of CaMKII at Thr286 and Ca2+-independent CaMKII activity in a cAMP-dependent manner. The blockade of LTP by a CaMKII inhibitor was not overcome by thiophosphorylated inhibitor-1. Thus, the cAMP pathway uses PP1 to gate CaMKII signaling in LTP.
Medical subject headings
- Calcium-Calmodulin-Dependent Protein Kinases
- Carrier Proteins
- Cyclic AMP
- Hippocampus
- Intracellular Signaling Peptides and Proteins
- Long-Term Potentiation
- Phosphoprotein Phosphatases
- Synapses